A Phase II Study of Trebananib (AMG 386) for the Treatment of Inoperable Advanced Angiosarcoma
[Protocol 12-128] |
D'Angelo, Sandra |
|
A Phase II Study of Tretinoin plus Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Therapy
[Protocol 11-040] |
Park, Jae |
- Leukemia
- Acute Myelogenous Leukemia
|
A Phase II Study of Veliparib plus Temozolomide, Veliparib plus Carboplatin and Paclitaxel, or Carboplatin and Paclitaxel with Placebo in Patients with BRCA Mutations and Metastatic Breast Cancer
[Protocol 12-122] |
Robson, Mark |
|
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131] |
Hyman, David |
- Hematology
- Hematologic Disorders
- Multiple Myeloma
|
A Phase II Study of Vemurafenib in Patients with Relapsed or Refractory Hairy Cell Leukemia
[Protocol 12-200] |
Park, Jae |
|
A Phase II Study of Vorinostat for Metastatic Uveal Melanoma
[Protocol 12-027] |
Carvajal, Richard |
|
A Phase II Study of WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma
[Protocol 10-134] |
Krug, Lee |
|
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
[Protocol 08-053] |
Krug, Lee |
|
A Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia
[Protocol 10-143] |
Maslak, Peter |
- Leukemia
- Acute Myelogenous Leukemia
|
A Phase II Trial of Bevacizumab, Cetuximab, Cisplatin, and Intensity-Modulated Radiation Therapy for Patients with Stage III/IV Head and Neck Squamous Cell Carcinoma
[Protocol 09-083] |
Fury, Matthew |
|
A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgery in Patients with Locally Advanced Thymoma
[Protocol 09-038] |
Huang, James |
|
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226] |
Molina, Ana Maria |
|
A Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients with Fanconi Anemia
[Protocol 08-031] |
Boulad, Farid |
- Blood and Marrow Transplantation
- Hematology
- Aplastic Anemia
- Myelodysplastic Syndrome
- Leukemia
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
|
A Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant
[Protocol 07-035] |
Hsu, Katharine |
- Blood & Marrow Stem Cell Transplantation
- Blood and Marrow Transplantation
- Hematology
- Leukemia
|
A Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Patients with Previously Untreated Advanced Germ Cell Tumors
[Protocol 07-044] |
Feldman, Darren |
|
A Phase II Trial of Temozolomide versus AZD6244 in Patients with Metastatic Uveal Melanoma
[Protocol 10-053] |
Carvajal, Richard |
|
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders
[Protocol 10-050] |
O'Reilly, Richard |
- Blood and Marrow Transplantation
- Hematology
- Multiple Myeloma
- Myelodysplastic Syndrome
- Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
- Lymphoma
|
A Phase II Trial of Vinorelbine and Cyclophosphamide with Bevacizumab or Temsirolimus in Patients with Recurrent/Refractory Rhabdomyosarcoma
[Protocol 11-026] |
Wexler, Leonard |
- Sarcomas
- Rhabdomyosarcoma
- Soft Tissue Sarcoma
|
A Phase II/III Study of Radiation Therapy plus Vorinostat, Temozolomide, or Bevacizumab followed by Maintenance Bevacizumab/Temozolomide in Children with Newly Diagnosed High-Grade Gliomas
[Protocol 12-082] |
Gilheeney, Stephen |
|
A Phase II/III Study of Sirolimus plus Prednisone, Sirolimus/Extracorporeal Photopheresis plus Prednisone, and Sirolimus/Calcineurin Inhibitor plus Prednisone for the Treatment of Chronic Graft-versus-Host-Disease
[Protocol 10-201] |
Goldberg, Jenna |
- Blood and Marrow Transplantation
|
